CVRx Inc (CVRX) Actualités

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

MINNEAPOLIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025

MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

CVRx Reports Third Quarter 2024 Financial and Operating Results

MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical...

CVRx announces new CPT® Category I codes for Barostim

MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical...

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

MINNEAPOLIS, Oct. 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical...

Form 8-K - Current report

CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim

New data published in JACC: Heart Failure demonstrate durable benefits in MLWHF and EQ-5D quality of life...